These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 19503766)
1. Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review. Carranza-Lira S Clin Interv Aging; 2009; 4():59-62. PubMed ID: 19503766 [TBL] [Abstract][Full Text] [Related]
2. Clinical responses to the combination of estradiol and drospirenone in symptomatic postmenopausal Thai women. Chaikittisilpa S; Angsuwathana S; Chaovisitsaree S; Jirapinyo M; Wilawan K; Panyakhamlerd K; Jaisamrarn U; Techatraisak K; Morakote N; Suchartwatnachai C; Kongmephol W; Taechakraichana N J Med Assoc Thai; 2011 Sep; 94(9):1019-25. PubMed ID: 21970189 [TBL] [Abstract][Full Text] [Related]
3. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial. Archer DF; Thorneycroft IH; Foegh M; Hanes V; Glant MD; Bitterman P; Kempson RL Menopause; 2005; 12(6):716-27. PubMed ID: 16278615 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study]. Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370 [TBL] [Abstract][Full Text] [Related]
6. Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study. Paoletti AM; Cagnacci A; Di Carlo C; Orrù MM; Neri M; D'Alterio MN; Melis GB Gynecol Endocrinol; 2015 May; 31(5):384-7. PubMed ID: 25703254 [TBL] [Abstract][Full Text] [Related]
8. Drospirenone, a new progestogen, for postmenopausal women with hypertension. Mallareddy M; Hanes V; White WB Drugs Aging; 2007; 24(6):453-66. PubMed ID: 17571911 [TBL] [Abstract][Full Text] [Related]
9. A randomized trial on the effect of oral combined estradiol and drospirenone on glucose and insulin metabolism in healthy menopausal women with a normal oral glucose tolerance test. Depypere H; Dierickx A; Vandevelde F; Stanczyk F; Ottoy L; Delanghe J; Lapauw B Maturitas; 2020 Aug; 138():36-41. PubMed ID: 32631586 [TBL] [Abstract][Full Text] [Related]
10. The effects of 17β-estradiol plus drospirenone on anthropometric and biochemical measures of adiposity in menopausal women. Karakus M; Gelisgen R; Topcuoglu A; Guralp O; Topcuoglu D; Simsek G; Uludag S; Uzun H Arch Gynecol Obstet; 2012 Nov; 286(5):1233-9. PubMed ID: 22791413 [TBL] [Abstract][Full Text] [Related]
11. Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women. Vitale C; Mammi C; Gambacciani M; Russo N; Spoletini I; Fini M; Volterrani M; Rosano GMC Int J Cardiol; 2017 Jan; 227():217-221. PubMed ID: 27843051 [TBL] [Abstract][Full Text] [Related]
12. 0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes. Gerlinger C; Gude K; Schmelter T; Schaefers M; Endrikat J Climacteric; 2015; 18(4):512-7. PubMed ID: 26000627 [TBL] [Abstract][Full Text] [Related]
13. Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension. White WB; Hanes V; Chauhan V; Pitt B Hypertension; 2006 Aug; 48(2):246-53. PubMed ID: 16801478 [TBL] [Abstract][Full Text] [Related]
14. Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome. Rizzo MR; Leo S; De Franciscis P; Colacurci N; Paolisso G Age (Dordr); 2014 Feb; 36(1):265-74. PubMed ID: 23832170 [TBL] [Abstract][Full Text] [Related]
15. Added benefits of drospirenone for compliance. Foidart JM Climacteric; 2005 Oct; 8 Suppl 3():28-34. PubMed ID: 16203653 [TBL] [Abstract][Full Text] [Related]
16. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Oelkers WH Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652 [TBL] [Abstract][Full Text] [Related]
17. Drospirenone and estradiol: a new option for the postmenopausal woman. Archer DF Climacteric; 2007 Feb; 10 Suppl 1():3-10. PubMed ID: 17364592 [TBL] [Abstract][Full Text] [Related]
18. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Oelkers WK Steroids; 1996 Apr; 61(4):166-71. PubMed ID: 8732994 [TBL] [Abstract][Full Text] [Related]
19. Effect of estradiol-drospirenone hormone treatment on myocardial perfusion reserve in postmenopausal women with angina pectoris. Knuuti J; Kalliokoski R; Janatuinen T; Hannukainen J; Kalliokoski KK; Koskenvuo J; Lundt S Am J Cardiol; 2007 Jun; 99(12):1648-52. PubMed ID: 17560868 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis. Warming L; Ravn P; Nielsen T; Christiansen C Climacteric; 2004 Mar; 7(1):103-11. PubMed ID: 15259289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]